US4900303A
(en)
*
|
1978-03-10 |
1990-02-13 |
Lemelson Jerome H |
Dispensing catheter and method
|
JPS5562012A
(en)
*
|
1978-11-06 |
1980-05-10 |
Teijin Ltd |
Slow-releasing preparation
|
US4842854A
(en)
*
|
1979-05-29 |
1989-06-27 |
Vsesojuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskiki Nauk Ssr |
Antianginal plate for treating ischemic heart disease
|
US4921695A
(en)
*
|
1979-05-29 |
1990-05-01 |
Babaian Eduard A |
Antianginal plate for treating ischemic heart disease
|
US4713239A
(en)
*
|
1979-05-29 |
1987-12-15 |
Vsesojuny Kardiologichesky Nauchny Tsentr Adkaemii Meditsinski Nauk Sssr |
Antianginal film and method of treating ischemic heart disease
|
US4394390A
(en)
*
|
1979-08-03 |
1983-07-19 |
University Of Kentucky Research Foundation |
Nasal dosage forms of propranol
|
US4291015A
(en)
*
|
1979-08-14 |
1981-09-22 |
Key Pharmaceuticals, Inc. |
Polymeric diffusion matrix containing a vasodilator
|
DE3066859D1
(en)
*
|
1979-10-26 |
1984-04-12 |
Smith & Nephew Ass |
Autoclavable emulsions
|
JPS5668609A
(en)
*
|
1979-11-07 |
1981-06-09 |
Nippon Kayaku Co Ltd |
Phthalazinol preparation
|
JPS572218A
(en)
*
|
1980-06-05 |
1982-01-07 |
Shionogi & Co Ltd |
Capsule agent for rectal administration
|
CA1163195A
(en)
*
|
1980-06-26 |
1984-03-06 |
Alec D. Keith |
Polymeric diffusion matrix containing a vasodilator
|
US4423099A
(en)
*
|
1980-07-28 |
1983-12-27 |
Ciba-Geigy Corporation |
Membrane modified hydrogels
|
HU187313B
(en)
*
|
1980-10-03 |
1985-12-28 |
Andras Sugar |
Dental cosmetic prparation
|
JPS5843368B2
(ja)
*
|
1980-10-30 |
1983-09-27 |
日東電工株式会社 |
消炎鎮痛貼付剤
|
US4329333A
(en)
*
|
1980-11-24 |
1982-05-11 |
Arthur Barr |
Method for the oral treatment of dogs and other animals
|
JPS57110254A
(en)
*
|
1980-12-29 |
1982-07-09 |
Teijin Ltd |
Coating agent of injured membrane part of oral cavity
|
US4428883A
(en)
*
|
1981-03-06 |
1984-01-31 |
The University Of Kentucky Research Foundation |
Novel method of administering β-blockers and novel dosage forms containing same
|
JPS57188526A
(en)
*
|
1981-05-14 |
1982-11-19 |
Takeda Chem Ind Ltd |
Peptide-containing pharmaceutical preparation
|
GB2108517B
(en)
*
|
1981-06-12 |
1985-06-12 |
Nat Res Dev |
Hydrogels
|
DE3125178A1
(de)
*
|
1981-06-26 |
1983-01-13 |
Gödecke AG, 1000 Berlin |
Verfahren zur zeitlichen steuerung der freisetzung von wirkstoffen aus wirkstoffzubereitungen, insbesondere arzneimittelzubereitungen
|
CA1218604A
(en)
*
|
1981-07-08 |
1987-03-03 |
Alec D. Keith |
Trinitroglycerol sustained release vehicles and preparations therefrom
|
SU1011126A1
(ru)
*
|
1981-07-14 |
1983-04-15 |
Всесоюзный научно-исследовательский и испытательный институт медицинской техники |
Средство дл лечени сахарного диабета
|
US4482533A
(en)
*
|
1982-01-11 |
1984-11-13 |
Key Pharmaceuticals, Inc. |
Polymeric diffusion matrix containing propranolol
|
JPS5948409A
(ja)
*
|
1982-09-10 |
1984-03-19 |
Teikoku Seiyaku Kk |
矯正的歯牙移動促進剤
|
CA1208558A
(en)
*
|
1982-10-07 |
1986-07-29 |
Kazuo Kigasawa |
Soft buccal
|
AU1873783A
(en)
*
|
1982-10-08 |
1984-04-12 |
Verex Laboratories Inc. |
Constant release formulation
|
IL70071A
(en)
*
|
1982-11-01 |
1987-12-31 |
Merrell Dow Pharma |
Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
|
US5910304A
(en)
*
|
1982-12-13 |
1999-06-08 |
Texas A&M University System |
Low-dose oral administration of interferons
|
US4461759A
(en)
*
|
1983-01-03 |
1984-07-24 |
Verex Laboratories, Inc. |
Constant release rate solid oral dosage formulations of veropamil
|
JPS59163313A
(ja)
*
|
1983-03-09 |
1984-09-14 |
Teijin Ltd |
経鼻投与用ペプチドホルモン類組成物
|
GB8514090D0
(en)
*
|
1985-06-04 |
1985-07-10 |
Sandoz Ltd |
Organic compounds
|
EP0139127A1
(en)
*
|
1983-08-22 |
1985-05-02 |
F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft |
Transdermal drug delivery device and its preparation
|
US4685883A
(en)
*
|
1983-09-12 |
1987-08-11 |
Jernberg Gary R |
Local delivery of chemotherapeutic agents for the treatment of periodontal disease
|
US4774091A
(en)
*
|
1983-10-14 |
1988-09-27 |
Sumitomo Pharmaceuticals Company, Ltd. |
Long-term sustained-release preparation
|
US4855134A
(en)
*
|
1983-10-14 |
1989-08-08 |
Sumitomo Pharmaceuticals Company, Limited |
Sustained-release preparation
|
US5385738A
(en)
*
|
1983-10-14 |
1995-01-31 |
Sumitomo Pharmaceuticals Company, Ltd. |
Sustained-release injection
|
DE3486029T2
(de)
*
|
1983-10-14 |
1993-05-13 |
Sumitomo Pharma |
Ifn-praeparat mit verzoegerter abgabe fuer parentale verabreichung.
|
US4983392A
(en)
*
|
1983-11-14 |
1991-01-08 |
Bio-Mimetics, Inc. |
Bioadhesive compositions and methods of treatment therewith
|
EP0501523B1
(en)
*
|
1983-11-14 |
1997-04-09 |
Columbia Laboratories, Inc. |
Bioadhesive compositions
|
US4795436A
(en)
*
|
1983-11-14 |
1989-01-03 |
Bio-Mimetics, Inc. |
Bioadhesive composition and method of treatment therewith
|
US4680323A
(en)
*
|
1983-12-01 |
1987-07-14 |
Hans Lowey |
Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
|
GB8403360D0
(en)
*
|
1984-02-08 |
1984-03-14 |
Erba Farmitalia |
Pharmaceutical compositions
|
GB8403359D0
(en)
*
|
1984-02-08 |
1984-03-14 |
Erba Farmitalia |
Pharmaceutical compositions
|
US4552899A
(en)
*
|
1984-04-09 |
1985-11-12 |
Analgesic Associates |
Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
|
DE3580384D1
(de)
*
|
1984-04-09 |
1990-12-13 |
Toyo Boseki |
Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle.
|
US5855908A
(en)
*
|
1984-05-01 |
1999-01-05 |
University Of Utah Research Foundation |
Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
|
US4863737A
(en)
*
|
1985-05-01 |
1989-09-05 |
University Of Utah |
Compositions and methods of manufacture of compressed powder medicaments
|
JPH0710771B2
(ja)
*
|
1984-10-23 |
1995-02-08 |
ナステツク フア−マス−テイカル カンパニ−、インコ−ポレイテツド |
抗吐き気および抗嘔吐薬剤の新規な投与組成物
|
US4749700A
(en)
*
|
1984-10-23 |
1988-06-07 |
Nastech Pharmaceutical Co, Inc. |
Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
|
US4701320A
(en)
*
|
1984-11-29 |
1987-10-20 |
Lederle (Japan), Ltd. |
Composition stably containing minocycline for treating periodontal diseases
|
US4568536A
(en)
*
|
1985-02-08 |
1986-02-04 |
Ethicon, Inc. |
Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
|
US4778786A
(en)
*
|
1985-04-03 |
1988-10-18 |
Minnetonka, Inc. |
Composition for transdermal drug delivery
|
US5132114A
(en)
*
|
1985-05-01 |
1992-07-21 |
University Of Utah Research Foundation |
Compositions and methods of manufacture of compressed powder medicaments
|
US5288497A
(en)
*
|
1985-05-01 |
1994-02-22 |
The University Of Utah |
Compositions of oral dissolvable medicaments
|
US5122127A
(en)
*
|
1985-05-01 |
1992-06-16 |
University Of Utah |
Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
|
US4885173A
(en)
*
|
1985-05-01 |
1989-12-05 |
University Of Utah |
Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
|
US4666705A
(en)
*
|
1985-06-03 |
1987-05-19 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
EP0205336B1
(en)
*
|
1985-06-11 |
1991-09-11 |
Teijin Limited |
Oral sustained release pharmaceutical preparation
|
GB8514665D0
(en)
*
|
1985-06-11 |
1985-07-10 |
Eroceltique Sa |
Oral pharmaceutical composition
|
US4729997A
(en)
*
|
1985-10-15 |
1988-03-08 |
Nastech Pharmaceutical Co., Inc. |
Novel method of administering meclizine type pharmaceutical agents and novel dosage forms containing same
|
JPS62120315A
(ja)
*
|
1985-11-20 |
1987-06-01 |
Shin Etsu Chem Co Ltd |
経口投与型徐放性錠剤の製造方法
|
JPS62123112A
(ja)
*
|
1985-11-22 |
1987-06-04 |
Sunstar Inc |
軟膏基剤
|
DE3688188T2
(de)
*
|
1985-12-27 |
1993-10-14 |
Koken Kk |
Verfahren zur Herstellung einer Formulierung mit verzögerter Freisetzung.
|
US4755386A
(en)
*
|
1986-01-22 |
1988-07-05 |
Schering Corporation |
Buccal formulation
|
DE3601923A1
(de)
*
|
1986-01-23 |
1987-07-30 |
Behringwerke Ag |
Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung
|
IE59361B1
(en)
*
|
1986-01-24 |
1994-02-09 |
Akzo Nv |
Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
|
US4764378A
(en)
*
|
1986-02-10 |
1988-08-16 |
Zetachron, Inc. |
Buccal drug dosage form
|
US4849227A
(en)
*
|
1986-03-21 |
1989-07-18 |
Eurasiam Laboratories, Inc. |
Pharmaceutical compositions
|
US4780320A
(en)
*
|
1986-04-29 |
1988-10-25 |
Pharmetrix Corp. |
Controlled release drug delivery system for the periodontal pocket
|
US5560909A
(en)
*
|
1986-06-03 |
1996-10-01 |
Dowelanco |
Insecticidal compositions and process for preparation thereof
|
US4713243A
(en)
*
|
1986-06-16 |
1987-12-15 |
Johnson & Johnson Products, Inc. |
Bioadhesive extruded film for intra-oral drug delivery and process
|
JPH0794384B2
(ja)
*
|
1986-09-01 |
1995-10-11 |
帝国製薬株式会社 |
徐放性口腔内用製剤
|
US5213615A
(en)
*
|
1986-10-11 |
1993-05-25 |
Ivoclar Ag |
Dental material and method for the control of caries and paradentitis
|
CA1320905C
(en)
*
|
1986-11-06 |
1993-08-03 |
Joseph M. Cummins |
Treatment of immuno-resistant disease
|
ZA878295B
(en)
*
|
1986-11-06 |
1988-05-03 |
Amarillo Cell Culture Co. Inc. |
Treatment of immuno-resistant disease
|
US4975270A
(en)
*
|
1987-04-21 |
1990-12-04 |
Nabisco Brands, Inc. |
Elastomer encased active ingredients
|
US5500228A
(en)
*
|
1987-05-26 |
1996-03-19 |
American Cyanamid Company |
Phase separation-microencapsulated pharmaceuticals compositions useful for alleviating dental disease
|
US4789547A
(en)
*
|
1987-06-17 |
1988-12-06 |
Warner-Lambert Company |
Transdermal matrix system
|
US4927816A
(en)
*
|
1987-08-20 |
1990-05-22 |
Ester George C |
Formulae and methods for sublingual ingestion of natural progesterone
|
US4915948A
(en)
*
|
1987-08-31 |
1990-04-10 |
Warner-Lambert Company |
Tablets having improved bioadhesion to mucous membranes
|
FR2619718B1
(fr)
*
|
1987-09-02 |
1991-07-12 |
Medibrevex |
Nouvelles formes galeniques de beta-2-mimetiques pour administration par voie per- et sublinguale
|
US4837030A
(en)
*
|
1987-10-06 |
1989-06-06 |
American Cyanamid Company |
Novel controlled release formulations of tetracycline compounds
|
GB8723846D0
(en)
*
|
1987-10-10 |
1987-11-11 |
Danbiosyst Ltd |
Bioadhesive microsphere drug delivery system
|
US4978391A
(en)
*
|
1987-11-13 |
1990-12-18 |
Dentsply Management Corp. |
Intraoral medicament delivery and procedure
|
ES2061688T3
(es)
*
|
1987-11-13 |
1994-12-16 |
Smithkline Beecham Farma |
Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
|
US5051261A
(en)
*
|
1987-11-24 |
1991-09-24 |
Fmc Corporation |
Method for preparing a solid sustained release form of a functionally active composition
|
CA1334379C
(en)
*
|
1987-11-24 |
1995-02-14 |
James William Mcginity |
Method for preparing a solid sustained release form of a functionally active composition
|
US5017371A
(en)
*
|
1988-01-06 |
1991-05-21 |
Amarillo Cell Culture Company, Incorporated |
Method for reducing side effects of cancer therapy
|
US5081158A
(en)
*
|
1988-05-02 |
1992-01-14 |
Zila Pharmaceuticals, Inc. |
Compositions and in situ methods for forming films on body tissue
|
US5081157A
(en)
*
|
1988-05-02 |
1992-01-14 |
Zila Pharmaceuticals, Inc. |
Compositions and in situ methods for forming films on body tissue
|
US4973596A
(en)
*
|
1988-05-20 |
1990-11-27 |
Barr Laboratories, Inc. |
Method of administering a narcotic analgesic and dosage forms therefor
|
US5073374A
(en)
*
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
US5112616A
(en)
*
|
1988-11-30 |
1992-05-12 |
Schering Corporation |
Fast dissolving buccal tablet
|
US4940579A
(en)
*
|
1988-12-27 |
1990-07-10 |
Minnesota Mining And Manufacturing Company |
Topical application of medicament in a binder
|
US5554388A
(en)
*
|
1989-02-25 |
1996-09-10 |
Danbiosyst Uk Limited |
Systemic drug delivery compositions comprising a polycationi substance
|
US5085865A
(en)
*
|
1989-04-12 |
1992-02-04 |
Warner-Lambert Company |
Sustained release pharmaceutical preparations containing an analgesic and a decongestant
|
IT8920486A0
(it)
*
|
1989-05-12 |
1989-05-12 |
Isf Spa |
Composizioni farmaceutiche.
|
WO1990015568A2
(en)
*
|
1989-06-02 |
1990-12-27 |
Stanley Theodore H |
Apparatus and methods for noninvasive blood glucose monitoring
|
US5139023A
(en)
*
|
1989-06-02 |
1992-08-18 |
Theratech Inc. |
Apparatus and method for noninvasive blood glucose monitoring
|
DK0431719T3
(da)
|
1989-10-31 |
1995-02-27 |
Columbia Lab Inc |
Vaginalt vævsbefugtende præparat
|
US5262164A
(en)
*
|
1989-11-17 |
1993-11-16 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
US5173299A
(en)
*
|
1989-11-17 |
1992-12-22 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
US5084267A
(en)
*
|
1989-11-17 |
1992-01-28 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
US5197882A
(en)
*
|
1990-05-14 |
1993-03-30 |
Gary R. Jernberg |
Periodontal barrier and method for aiding periodontal tissue regeneration agents
|
US5059123A
(en)
*
|
1990-05-14 |
1991-10-22 |
Jernberg Gary R |
Periodontal barrier and method for aiding periodontal tissue regeneration
|
US5290271A
(en)
*
|
1990-05-14 |
1994-03-01 |
Jernberg Gary R |
Surgical implant and method for controlled release of chemotherapeutic agents
|
NL9002008A
(nl)
|
1990-09-12 |
1992-04-01 |
Stichting Centr Diergeneeskund |
Recombinant dna en rna en daarvan afgeleide produkten.
|
US5114718A
(en)
*
|
1990-09-20 |
1992-05-19 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontol disease
|
EP0580861B1
(en)
*
|
1991-04-08 |
1998-09-09 |
Nippon Shinyaku Company, Limited |
Sustained release capsule for adhesion in the gastrointestinal tract
|
TW209174B
(US20100154141A1-20100624-C00001.png)
|
1991-04-19 |
1993-07-11 |
Takeda Pharm Industry Co Ltd |
|
US5250293A
(en)
*
|
1991-04-22 |
1993-10-05 |
Gleich Gerald J |
Method for the treatment of hypersensitivity diseases by administration of anionic polymers
|
US5681555A
(en)
*
|
1991-04-22 |
1997-10-28 |
Gleich; Gerald J. |
Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
|
US5498410A
(en)
*
|
1991-04-22 |
1996-03-12 |
Gleich; Gerald J. |
Method for the treatment of eosinophil-associated conditions with anionic polymers
|
IT1250421B
(it)
*
|
1991-05-30 |
1995-04-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
|
US5571533A
(en)
*
|
1992-02-07 |
1996-11-05 |
Recordati, S.A., Chemical And Pharmaceutical Company |
Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
|
GR1002418B
(el)
*
|
1992-07-29 |
1996-08-21 |
Johnson & Johnson Consumer Products Inc. |
Βιοεπισυναπτομενες συνθεσεις θεραπειας και μεθοδοι χρησης.
|
US5700485A
(en)
*
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
ES2170074T3
(es)
*
|
1992-09-10 |
2002-08-01 |
Childrens Medical Center |
Matrices de polimero biodegradables para la liberacion prolongada de agentes anestesicos locales.
|
US5922340A
(en)
*
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
US5981591A
(en)
*
|
1992-12-04 |
1999-11-09 |
Mayor Pharmaceutical Laboratories, Inc. |
Sprayable analgesic composition and method of use
|
US5447725A
(en)
*
|
1993-06-11 |
1995-09-05 |
The Procter & Gamble Company |
Methods for aiding periodontal tissue regeneration
|
JPH0776527A
(ja)
*
|
1993-06-28 |
1995-03-20 |
Hayashibara Biochem Lab Inc |
半固形製剤とその製造方法
|
EP0722312B1
(en)
*
|
1993-10-04 |
2001-01-03 |
Maurizio Dr. Tonetti |
Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it
|
US5451409A
(en)
*
|
1993-11-22 |
1995-09-19 |
Rencher; William F. |
Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
|
FR2712807B1
(fr)
*
|
1993-11-24 |
1996-02-23 |
Vetoquinol Sa |
Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
|
US5578315A
(en)
*
|
1993-12-01 |
1996-11-26 |
Rutgers, The State University Of New Jersey |
Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
|
US5458879A
(en)
*
|
1994-03-03 |
1995-10-17 |
The Procter & Gamble Company |
Oral vehicle compositions
|
FR2718020B1
(fr)
*
|
1994-04-01 |
1996-05-31 |
Biotec Centre Sa |
Composition galénique mucoadhésive hétérofonctionnelle.
|
US5879712A
(en)
*
|
1995-06-07 |
1999-03-09 |
Sri International |
Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
|
CA2195119C
(en)
|
1995-06-09 |
2001-09-11 |
Mark Chasin |
Formulations and methods for providing prolonged local anesthesia
|
US5741525A
(en)
*
|
1995-10-24 |
1998-04-21 |
Marshall University Research Corporation |
Vaginal pharmaceutical hydrogen peroxide composition
|
US6596777B1
(en)
|
1997-05-29 |
2003-07-22 |
Mcneil-Ppc, Inc. |
Moisture containing compositions that are spreadable onto and adherable to biomembranes
|
EP0954301A4
(en)
|
1996-06-24 |
2006-03-08 |
Euro Celtique Sa |
SAFE METHODS OF LOCAL ANESTHESIA
|
US5976573A
(en)
*
|
1996-07-03 |
1999-11-02 |
Rorer Pharmaceutical Products Inc. |
Aqueous-based pharmaceutical composition
|
US6046187A
(en)
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
JP3020141B2
(ja)
*
|
1996-10-07 |
2000-03-15 |
株式会社富士薬品 |
経鼻投与用製剤
|
US5800832A
(en)
*
|
1996-10-18 |
1998-09-01 |
Virotex Corporation |
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
|
US5955097A
(en)
*
|
1996-10-18 |
1999-09-21 |
Virotex Corporation |
Pharmaceutical preparation applicable to mucosal surfaces and body tissues
|
US6767925B1
(en)
*
|
1996-10-31 |
2004-07-27 |
Joseph A. Deihl |
Sprayable analgesic composition and method of use
|
KR100367144B1
(ko)
|
1997-07-02 |
2003-01-14 |
유로-셀티크 소시에떼 아노뉨 |
관절과 체강(body space)내에서 연장된 마취
|
US6123957A
(en)
*
|
1997-07-16 |
2000-09-26 |
Jernberg; Gary R. |
Delivery of agents and method for regeneration of periodontal tissues
|
US5989571A
(en)
*
|
1997-07-23 |
1999-11-23 |
Millenium Pharmaceutical Technologies, Inc. |
Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory
|
US6624200B2
(en)
|
1998-08-25 |
2003-09-23 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6248358B1
(en)
|
1998-08-25 |
2001-06-19 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets and methods of making and using the same
|
US20050048102A1
(en)
*
|
1997-10-16 |
2005-03-03 |
Virotex Corporation |
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
|
US5972327A
(en)
*
|
1997-10-22 |
1999-10-26 |
Lin; Matthew M. |
Method of treating allergic rhinitis by delivering medication via the nasal vestibules
|
US6103266A
(en)
*
|
1998-04-22 |
2000-08-15 |
Tapolsky; Gilles H. |
Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
|
US6190699B1
(en)
*
|
1998-05-08 |
2001-02-20 |
Nzl Corporation |
Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa
|
AU2003200753B2
(en)
*
|
1998-08-25 |
2005-05-12 |
Columbia Laboratories (Bermuda) Limited |
Bioadhesive Progressive Hydration Tablets
|
US7662409B2
(en)
*
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
US8197461B1
(en)
|
1998-12-04 |
2012-06-12 |
Durect Corporation |
Controlled release system for delivering therapeutic agents into the inner ear
|
US6159491A
(en)
*
|
1999-02-12 |
2000-12-12 |
Biovector Technologies, Inc. |
Prolonged release bioadhesive vaginal gel dosage form
|
JP4632499B2
(ja)
*
|
1999-08-26 |
2011-02-16 |
武田薬品工業株式会社 |
鼻粘膜付着マトリックス
|
CA2393231A1
(en)
*
|
1999-12-06 |
2001-06-07 |
Edward Mendell Co., Inc. |
Pharmaceutical superdisintegrant
|
US6432415B1
(en)
|
1999-12-17 |
2002-08-13 |
Axrix Laboratories, Inc. |
Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
|
JP5154726B2
(ja)
|
2000-02-17 |
2013-02-27 |
ネオメンド,インコーポレイティド |
予備成形された生分解性ポリマー組成物を使用したデリバリシステムおよび方法
|
US6812205B2
(en)
|
2000-03-15 |
2004-11-02 |
The Brigham & Women's Hospital, Inc. |
Suppression of vascular disorders by mucosal administration of heat shock protein peptides
|
US6494204B1
(en)
|
2000-06-23 |
2002-12-17 |
Pedro D. Ponce |
Nasal medication administering device
|
US20020013331A1
(en)
*
|
2000-06-26 |
2002-01-31 |
Williams Robert O. |
Methods and compositions for treating pain of the mucous membrane
|
US6635272B2
(en)
*
|
2000-11-09 |
2003-10-21 |
Richard N. Leaderman |
Wound dressing and drug delivery system
|
US6458380B1
(en)
*
|
2000-11-09 |
2002-10-01 |
Richard Leaderman |
Dressing and preparation delivery system
|
WO2002058670A1
(en)
*
|
2001-01-25 |
2002-08-01 |
Euroceltique S.A. |
Local anesthetic, and method of use
|
DE10107659B4
(de)
*
|
2001-02-19 |
2008-03-13 |
Lts Lohmann Therapie-Systeme Ag |
Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
|
ATE525061T1
(de)
*
|
2001-02-28 |
2011-10-15 |
Axiomedic Ltd |
Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
|
US8980334B2
(en)
*
|
2001-02-28 |
2015-03-17 |
Axiomedic Ltd. |
Double-layered absorbable solid compositions for the topical treatment of oral mucosal disorders
|
US20060073174A1
(en)
*
|
2001-08-16 |
2006-04-06 |
Access Pharmaceuticals, Inc. |
Adherent and erodible film to treat a moist surface of a body tissue
|
US6585997B2
(en)
|
2001-08-16 |
2003-07-01 |
Access Pharmaceuticals, Inc. |
Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US7910641B2
(en)
*
|
2001-10-12 |
2011-03-22 |
Monosol Rx, Llc |
PH modulated films for delivery of actives
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US20070154527A1
(en)
*
|
2001-10-12 |
2007-07-05 |
Monosoirx, Llc |
Topical film compositions for delivery of actives
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US7666337B2
(en)
*
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
US7425292B2
(en)
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
US20100021526A1
(en)
*
|
2001-10-12 |
2010-01-28 |
Monosol Rx, Llc |
Ph modulated films for delivery of actives
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US7357891B2
(en)
*
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US20030167556A1
(en)
*
|
2002-03-05 |
2003-09-11 |
Consumers Choice Systems, Inc. |
Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging
|
US8017150B2
(en)
*
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
WO2003092468A2
(en)
*
|
2002-04-29 |
2003-11-13 |
Gel-Del Technologies, Inc. |
Biomatrix structural containment and fixation systems and methods of use thereof
|
US20040111275A1
(en)
*
|
2002-11-15 |
2004-06-10 |
Kroll David B. |
Methods for marketing and generating revenue from edible thin films
|
US20040096569A1
(en)
*
|
2002-11-15 |
2004-05-20 |
Barkalow David G. |
Edible film products and methods of making same
|
US20040156794A1
(en)
*
|
2003-02-11 |
2004-08-12 |
Barkalow David G. |
Bioerodible and bioadhesive confectionery products and methods of making same
|
EA009714B1
(ru)
*
|
2003-03-28 |
2008-02-28 |
Арес Трейдинг С.А. |
Препараты кладрибина для улучшенной пероральной доставки и доставки через слизистые оболочки
|
US7276246B2
(en)
*
|
2003-05-09 |
2007-10-02 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7306812B2
(en)
*
|
2003-05-09 |
2007-12-11 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US20040265323A1
(en)
*
|
2003-05-16 |
2004-12-30 |
Mccormick Beth A. |
Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin A3), inhibitors thereof and methods of use thereof
|
US20040241294A1
(en)
*
|
2003-05-31 |
2004-12-02 |
Barabolak Roman M. |
Edible films including aspartame and methods of making same
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
WO2005011617A2
(en)
*
|
2003-07-31 |
2005-02-10 |
Ivax Corporation |
Transmucosal dosage forms for brain-targeted steroid chemical delivery systems
|
US20050036958A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Jianxun Feng |
Dental bleaching
|
EP1660013A4
(en)
|
2003-08-26 |
2011-07-20 |
Gel Del Technologies Inc |
BIOMATERIAL AND PROTEIN BIOCOACERVATES, METHODS OF MAKING AND USING THEM
|
US8529939B2
(en)
*
|
2003-12-08 |
2013-09-10 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
US20050143303A1
(en)
*
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
US20080318837A1
(en)
*
|
2003-12-26 |
2008-12-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
|
US20060074025A1
(en)
*
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
US20060210614A1
(en)
*
|
2003-12-26 |
2006-09-21 |
Nastech Pharmaceutical Company Inc. |
Method of treatment of a metabolic disease using intranasal administration of exendin peptide
|
US20050266031A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Jay Dickerson |
Pharmaceutical suspension composition
|
WO2006009764A1
(en)
*
|
2004-06-17 |
2006-01-26 |
Amano Enzyme Usa., Ltd. |
Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
|
US20060057165A1
(en)
*
|
2004-09-10 |
2006-03-16 |
Dimitrios Dimitrakoudis |
Clostridium botulinum toxin formulation and method for reducing weight
|
US8758816B2
(en)
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
KR20070104884A
(ko)
|
2004-11-24 |
2007-10-29 |
메드포인트 헬쓰케어 인크. |
아젤라스틴을 포함하는 조성물 및 이의 사용 방법
|
EP1835933A4
(en)
|
2005-01-04 |
2015-01-07 |
Yeda Res & Dev |
HSP60, PEPTIDES HSP60 AND T-CELL VACCINES FOR IMMUNOMODULATION
|
WO2006109312A2
(en)
*
|
2005-04-15 |
2006-10-19 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
|
CN101229378A
(zh)
*
|
2005-05-05 |
2008-07-30 |
国家淀粉及化学投资控股公司 |
用于送递活性剂的组合物
|
US20070059250A1
(en)
*
|
2005-09-12 |
2007-03-15 |
Nawaz Ahmad |
Sprayable personal lubricant
|
RU2008124109A
(ru)
*
|
2005-12-08 |
2010-01-20 |
МДРНА, Инк. (US) |
Чресслизистая доставка стабилизированных композиций эксендина
|
US20070185035A1
(en)
*
|
2005-12-23 |
2007-08-09 |
Nastech Pharmaceutical Company Inc. |
Enhanced mucosal administration of neuroprotective peptides
|
US8865743B2
(en)
|
2006-01-06 |
2014-10-21 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8202535B2
(en)
|
2006-01-06 |
2012-06-19 |
Acelrx Pharmaceuticals, Inc. |
Small-volume oral transmucosal dosage forms
|
US8535714B2
(en)
|
2006-01-06 |
2013-09-17 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8252329B2
(en)
|
2007-01-05 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US8753308B2
(en)
|
2006-01-06 |
2014-06-17 |
Acelrx Pharmaceuticals, Inc. |
Methods for administering small volume oral transmucosal dosage forms using a dispensing device
|
AU2007207503A1
(en)
*
|
2006-01-20 |
2007-07-26 |
Monosol Rx, Llc |
Film bandage for mucosal administration of actives
|
CA2636026A1
(en)
*
|
2006-01-20 |
2007-07-26 |
Monosol Rx, Llc |
Film lined pouch and method of manufacturing this pouch
|
US20070190013A1
(en)
*
|
2006-02-13 |
2007-08-16 |
Yeli Zhang |
Film and film-forming compositions
|
GB0604319D0
(en)
*
|
2006-03-03 |
2006-04-12 |
Optinose As |
Nasal delivery
|
CN103550136B
(zh)
|
2006-07-21 |
2016-04-13 |
生物递送科学国际公司 |
吸收增强的经粘膜递送装置
|
CN101516331A
(zh)
*
|
2006-09-20 |
2009-08-26 |
莫诺索尔克斯有限公司 |
含有抗泡沫调味剂的可食用水溶性膜
|
CA2664615A1
(en)
*
|
2006-09-29 |
2008-04-10 |
Monosol Rx, Llc |
Film embedded packaging and method of making same
|
US20120027855A1
(en)
|
2007-07-06 |
2012-02-02 |
Lupin Limited |
Pharmaceutical compositions for gastrointestinal drug delivery
|
EP3620153A1
(en)
|
2007-07-06 |
2020-03-11 |
Lupin Limited |
Pharmaceutical compositions for gastrointestinal drug delivery
|
WO2009008006A2
(en)
|
2007-07-06 |
2009-01-15 |
Lupin Limited |
Pharmaceutical compositions for gastrointestinal drug delivery
|
ES2534433T3
(es)
*
|
2007-08-07 |
2015-04-22 |
Acelrx Pharmaceuticals, Inc. |
Composiciones que comprenden sufentanilo y triazolam para sedación y analgesia operatorias utilizando formas farmacéuticas transmucosas orales
|
WO2009086483A2
(en)
|
2007-12-26 |
2009-07-09 |
Gel-Del Technologies, Inc. |
Biocompatible protein particles, particle devices and methods thereof
|
CN102176818A
(zh)
*
|
2008-08-12 |
2011-09-07 |
诺华贝制药公司 |
抗微生物凝胶制剂
|
US10016534B2
(en)
|
2008-11-17 |
2018-07-10 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
US8945592B2
(en)
|
2008-11-21 |
2015-02-03 |
Acelrx Pharmaceuticals, Inc. |
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
|
WO2010088697A2
(en)
*
|
2009-02-02 |
2010-08-05 |
Medtronic, Inc. |
Antimicrobial accessory for an implantable medical device
|
US20100278895A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Medtronic, Inc. |
Antioxidants and antimicrobial accessories including antioxidants
|
US20110123517A1
(en)
*
|
2009-06-11 |
2011-05-26 |
Medtronic, Inc. |
Dissolvable pharmaceutical implant
|
WO2010144849A2
(en)
*
|
2009-06-11 |
2010-12-16 |
Medtronic, Inc. |
Dissolvable pharmaceutical implant
|
US20110033515A1
(en)
*
|
2009-08-04 |
2011-02-10 |
Rst Implanted Cell Technology |
Tissue contacting material
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
US20110091544A1
(en)
*
|
2009-10-16 |
2011-04-21 |
Acelrx Pharmaceuticals, Inc. |
Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
|
US8701671B2
(en)
|
2011-02-04 |
2014-04-22 |
Joseph E. Kovarik |
Non-surgical method and system for reducing snoring
|
US9549842B2
(en)
|
2011-02-04 |
2017-01-24 |
Joseph E. Kovarik |
Buccal bioadhesive strip and method of treating snoring and sleep apnea
|
WO2011064316A2
(en)
|
2009-11-25 |
2011-06-03 |
Paolo Botti |
Mucosal delivery of peptides
|
WO2011137491A1
(en)
*
|
2010-05-06 |
2011-11-10 |
University Of South Australia |
Novel drug delivery system
|
JP5819949B2
(ja)
|
2010-06-10 |
2015-11-24 |
ミダテック リミテッド |
ナノ粒子フィルム送達システム
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
US8911427B2
(en)
|
2010-12-28 |
2014-12-16 |
Medtronic, Inc. |
Therapeutic agent reservoir delivery system
|
US11998479B2
(en)
|
2011-02-04 |
2024-06-04 |
Seed Health, Inc. |
Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
ES2660116T3
(es)
|
2011-08-18 |
2018-03-20 |
Biodelivery Sciences International, Inc. |
Dispositivos mucoadhesivos resistentes al uso inadecuado para la administración de buprenorfina
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
US20160106813A1
(en)
|
2013-03-29 |
2016-04-21 |
Centre National De La Recherche Schientifique (Cnrs) |
Cgrp receptor agonist for hiv treatment or prevention
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
US11998574B2
(en)
|
2013-12-20 |
2024-06-04 |
Seed Health, Inc. |
Method and system for modulating an individual's skin microbiome
|
US12005085B2
(en)
|
2013-12-20 |
2024-06-11 |
Seed Health, Inc. |
Probiotic method and composition for maintaining a healthy vaginal microbiome
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
EP2889030A1
(en)
|
2013-12-30 |
2015-07-01 |
Uluru Inc. |
Controlling the erosion rates of mucoadhesive devices that deliver actives and other compounds and providing increased and variable therapeutic blood levels
|
AU2015369710B2
(en)
|
2014-12-23 |
2020-09-17 |
Vertical Pharmaceuticals, Llc |
Systems, devices and methods for dispensing oral transmucosal dosage forms
|
JP2019519487A
(ja)
|
2016-05-05 |
2019-07-11 |
アクエスティブ セラピューティクス インコーポレイテッド |
送達増強エピネフリン組成物
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
CA3045118A1
(en)
*
|
2016-11-28 |
2018-05-31 |
Johnson & Johnson Consumer Inc. |
Liquid compositions comprising a mucoadhesive agent
|
WO2019032975A1
(en)
*
|
2017-08-10 |
2019-02-14 |
Mec Device Pharma International Llc |
ANTI-ABUSE MEDICINAL FORMULATIONS
|
CA3210217A1
(en)
*
|
2022-09-01 |
2024-03-01 |
Cav-Aid LLC |
Dental medicament applicator
|